The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 30, 2006
Filed:
Jan. 08, 2002
Ranga Madhavan Gurram, Ameerpet Hyderabad, IN;
Venkateswarlu Akella, Ameerpet Hyderabad, IN;
Rajagopalan Ramanujam, Ameerpet Hyderabad, IN;
Ranjan Chakrabarti, Ameerpet Hyderabad, IN;
Parimal Misra, Ameerpet Hyderabad, IN;
Vidya Bhushan Lohray, Ameerpet Hyderabad, IN;
Braj Bhushan Lohray, Ameerpet Hyderabad, IN;
Rao Bheema Paraselli, Ameerpet Hyderabad, IN;
Ranga Madhavan Gurram, Ameerpet Hyderabad, IN;
Venkateswarlu Akella, Ameerpet Hyderabad, IN;
Rajagopalan Ramanujam, Ameerpet Hyderabad, IN;
Ranjan Chakrabarti, Ameerpet Hyderabad, IN;
Parimal Misra, Ameerpet Hyderabad, IN;
Vidya Bhushan Lohray, Ameerpet Hyderabad, IN;
Braj Bhushan Lohray, Ameerpet Hyderabad, IN;
Rao Bheema Paraselli, Ameerpet Hyderabad, IN;
Dr. Reddy's Laboratories Limited, Hyderabad, IN;
Dr. Reddy's Laboratories, Inc., Bridgewater, NJ (US);
Abstract
The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel β-aryl-α-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds, their analogs, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to novel intermediates, processes for their preparation and their use in the preparation of compounds of formula (I).